Lupin incorporates wholly owned subsidiary

18 Mar 2025 Evaluate

Lupin has incorporated wholly-owned subsidiary namely ‘Lupinlife Consumer Healthcare’. The company has received certificate of incorporation from Ministry of Corporate Affairs on March 18, 2025.  

Earlier, the company had received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2079.50 -33.45 (-1.58%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×